These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22785051)

  • 21. Association of serum homocysteine levels with the severity and calcification of coronary atherosclerotic plaques detected by coronary CT angiography.
    Sun Q; Jia X; Gao J; Mou W; Tong H; Wen X; Tian Y
    Int Angiol; 2014 Aug; 33(4):316-23. PubMed ID: 25056163
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Kitagawa T; Yamamoto H; Toshimitsu S; Sasaki K; Senoo A; Kubo Y; Tatsugami F; Awai K; Hirokawa Y; Kihara Y
    Atherosclerosis; 2017 Aug; 263():385-392. PubMed ID: 28528743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of quantitative atherosclerotic plaque burden from coronary CT angiography in patients with first acute coronary syndrome and stable coronary artery disease.
    Dey D; Achenbach S; Schuhbaeck A; Pflederer T; Nakazato R; Slomka PJ; Berman DS; Marwan M
    J Cardiovasc Comput Tomogr; 2014; 8(5):368-74. PubMed ID: 25301042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels.
    Munir JA; Wu H; Bauer K; Bindeman J; Byrd C; Feuerstein IM; Villines TC; Taylor AJ
    Menopause; 2012 Jan; 19(1):10-5. PubMed ID: 21900851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
    Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.
    Falcone C; Bozzini S; Guasti L; D'Angelo A; Capettini AC; Paganini EM; Falcone R; Moia R; Gazzaruso C; Pelissero G
    ScientificWorldJournal; 2013; 2013():584504. PubMed ID: 24228009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of coronary CT angiography-derived quantitative markers for the prediction of major adverse cardiac events.
    Tesche C; Plank F; De Cecco CN; Duguay TM; Albrecht MH; Varga-Szemes A; Bayer RR; Yang J; Jacks IL; Gramer BM; Ebersberger U; Hoffmann E; Chiaramida SA; Feuchtner G; Schoepf UJ
    J Cardiovasc Comput Tomogr; 2016; 10(6):458-465. PubMed ID: 27522574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary calcifications and plaque characteristics in patients with end-stage renal disease: a computed tomographic study.
    Jug B; Kadakia J; Gupta M; Papazian J; Derakhshani A; Koplik S; Karlsberg RP; Budoff MJ
    Coron Artery Dis; 2013 Sep; 24(6):501-8. PubMed ID: 23811834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.
    Wang X; Xu T; Mungun D; Zhou C; Zha Z; Lu M; Fen C; Guo Y
    Dis Markers; 2019; 2019():4528382. PubMed ID: 31275446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Non-obstructive left main disease on the progression of coronary artery disease: A PARADIGM substudy.
    Weir-McCall JR; Blanke P; Sellers SL; Ahmadi AA; Andreini D; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Chun EJ; Conte E; Gottlieb I; Hadamitzky M; Kim YJ; Lee BK; Lee SE; Maffei E; Marques H; Pontone G; Raff GL; Shin S; Sung JM; Stone P; Samady H; Virmani R; Narula J; Berman DS; Shaw LJ; Bax JJ; Lin FY; Min JK; Chang HJ; Leipsic JA
    J Cardiovasc Comput Tomogr; 2018; 12(3):231-237. PubMed ID: 29802032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque.
    Korosoglou G; Lehrke S; Mueller D; Hosch W; Kauczor HU; Humpert PM; Giannitsis E; Katus HA
    Heart; 2011 May; 97(10):823-31. PubMed ID: 20884786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative atherosclerotic plaque volume by CT coronary angiography trumps conventional stenosis assessment for identifying flow-limiting lesions.
    Kato N; Kishi S; Arbab-Zadeh A; Rybicki FJ; Tanimoto S; Aoki J; Watanabe M; Horiuchi Y; Furui K; Hara K; Ibukuro K; Lima JAC; Tanabe K
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1847-1855. PubMed ID: 28597124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liberation of vessel-adherent myeloperoxidase reflects plaque burden in patients with stable coronary artery disease.
    Rudolph TK; Schaper N; Klinke A; Demir C; Goldmann B; Lau D; Köster R; Hellmich M; Meinertz T; Baldus S; Rudolph V
    Atherosclerosis; 2013 Dec; 231(2):354-8. PubMed ID: 24267251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo coronary lesion differentiation with computed tomography angiography and intravascular ultrasound as compared to optical coherence tomography.
    Wieringa WG; Lexis CP; Lipsic E; van der Werf HW; Burgerhof JG; Hagens VE; Bartels GL; Broersen A; Schurer RA; Tan ES; van der Harst P; van den Heuvel AF; Willems TP; Pundziute G
    J Cardiovasc Comput Tomogr; 2017; 11(2):111-118. PubMed ID: 28169175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Walking and Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study.
    Imran TF; Patel Y; Ellison RC; Carr JJ; Arnett DK; Pankow JS; Heiss G; Hunt SC; Gaziano JM; Djoussé L
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1272-7. PubMed ID: 27102966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease.
    Basta G; Leonardis D; Mallamaci F; Cutrupi S; Pizzini P; Gaetano L; Tripepi R; Tripepi G; De Caterina R; Zoccali C
    Kidney Int; 2010 Feb; 77(3):225-31. PubMed ID: 19924100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.